What amount sold does RHF IV Holding Company, LLC report in Form D filings?

The latest linked filings report $34.9M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was RHF IV Holding Company, LLC's most recent SEC filing?

RHF IV Holding Company, LLC's most recent Form D filing was on 2024-01-17.

How many investors does RHF IV Holding Company, LLC have?

The most recent Form D filing lists 125 investor(s).

What type of securities does RHF IV Holding Company, LLC offer?

RHF IV Holding Company, LLC's SEC Form D filings indicate equity offerings.

RHF IV Holding Company, LLC

CIK: 0002008220·Biotechnology·PARK CITY, UT·Limited Liability Company·Founded 2023

Reported Sold

$34,940,000

Total Filings

Identified Offerings

Last Filed

Jan 17, 2024

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jan 17, 2024Form D — New notice

Reported sold: $34,940,000 · Target: $35,000,000

Rule 506(b)·125 investors·Section 3(c), Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

125

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$226,300

Amendment Rate

Latest reported sold across 1 identified offering

$34,940,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Marc S. Bathgate

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 17, 2024	New	$35,000,000	$34,940,000	125

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Lion River Fund LLC

Biotechnology

Offering target: $25,000,000

Filed Aug 31, 2026